Combination of Olaparib and Navitoclax in Women with HGSC and TNBC

Clinical trial NCT05358639 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05358639
Sponsor: Sunnybrook Health Sciences Centre
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

High Grade Serous Carcinoma Triple Negative Breast Cancer Ovarian Cancer

Start date: 2022-11-09
Primary completion: 2025-03-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.